Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - susp. inj. in stilou injector preumplut - 100u/ml - insuline si analogi insuline si analogi act. interm. comb.cu act. rapida, inject

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - susp. inj. in cartus - 100u/ml - insuline si analogi insuline si analogi act. interm. comb.cu act. rapida, inject

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - susp. inj. - 100u/ml - insuline si analogi insuline si analogi act. interm. comb.cu act. rapida, inject

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - susp. inj. in cartus - 100u/ml - insuline si analogi insuline si analogi act. interm. comb.cu act. rapida, inject

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - sol. inj. in flacon - 100unitati/ml - insuline si analogi insuline si analogi cu actiune rapida

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - sol. inj. - 100unitati/ml - insuline si analogi insuline si analogi cu actiune rapida

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - sol. inj. in stilou injector preumplut - 100unitati/ml - insuline si analogi insuline si analogi cu actiune rapida

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - sol. inj. in stilou injector preumplut - 100unitati/ml - insuline si analogi insuline si analogi cu actiune rapida

Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

novo nordisk a/s - danemarca - insulinum aspart - sol. inj. in cartus - 100unitatiml - insuline si analogi insuline si analogi cu actiune rapida

Европейски съюз - румънски - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresoare - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).